Astrazeneca (AZN) EV to FCF (2009 - 2026)
Astrazeneca (AZN) EV to FCF (2009 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to FCF |
| 1 |
Gsk |
92,134,969.93 Bn |
92,134,964.97 Bn |
7.76 Bn |
16.40 Mn |
| 2 |
Eli Lilly |
1,027.45 Bn |
1,022.17 Bn |
16.22 Bn |
86.46 |
| 3 |
Johnson & Johnson |
559.08 Bn |
537.03 Bn |
15.96 Bn |
30.20 |
| 4 |
AbbVie |
394.75 Bn |
385.40 Bn |
10.78 Bn |
19.29 |
| 5 |
Merck |
295.12 Bn |
289.47 Bn |
12.09 Bn |
20.51 |
| 6 |
Amgen |
186.65 Bn |
174.61 Bn |
5.87 Bn |
20.31 |
| 7 |
Gilead Sciences |
159.22 Bn |
151.50 Bn |
5.52 Bn |
14.81 |
| 8 |
Pfizer |
146.00 Bn |
133.23 Bn |
-1.21 Bn |
14.05 |
| 9 |
Bristol Myers Squibb |
113.22 Bn |
102.77 Bn |
8.07 Bn |
8.63 |
| 10 |
Astrazeneca |
70.52 Bn |
62.58 Bn |
12.61 Bn |
-23.25 |
| Date | Value |
|---|
| Jun 8, 2026 |
-23.25 |
| Jun 5, 2026 |
-23.85 |
| Jun 4, 2026 |
-23.25 |
| Jun 3, 2026 |
-22.46 |
| Jun 2, 2026 |
-22.60 |
| Jun 1, 2026 |
4.03 |
| May 29, 2026 |
4.16 |
| May 28, 2026 |
4.15 |
| May 27, 2026 |
4.16 |
| May 26, 2026 |
4.19 |
| May 22, 2026 |
4.19 |
| May 21, 2026 |
-0.48 |
| May 20, 2026 |
-0.48 |
| May 19, 2026 |
-0.48 |
| May 18, 2026 |
-0.48 |
| May 15, 2026 |
-0.48 |
| May 14, 2026 |
-0.48 |
| May 13, 2026 |
-0.48 |
| May 12, 2026 |
-0.48 |
| May 11, 2026 |
-0.48 |
